Cancer Research6 天
Repurposing the DNA Labeling Agent EdU for Therapy Against Heterogeneous Patient Glioblastoma
Copyright held by the owner/author(s).
Cancer Research5 天
Enhanced Antitumor Immunity by ASP1570, a Novel Diacylglycerol Kinase Zeta Inhibitor ...
Copyright held by the owner/author(s).
Cancer Research5 天
Therapeutic Targeting of BET proteins in Sarcoma
Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International ...
Cancer Research6 天
Limited Awareness of Alcohol-Related Cancer Risk Factors among Spanish-Preferring Adults in ...
1Department of Communication, University of Utah, Salt Lake City, Utah. 2Huntsman Cancer Institute, Salt Lake City, Utah. *Corresponding Author: Yi Liao, Department of Communication, University of ...
Cancer Research5 天
Cancer-Associated Fibroblasts Foster a High-Lactate Microenvironment to Drive Perineural ...
Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International ...
Cancer Research6 天
Ovarian Cancer Trial Brought to a Halt
Waltham, MA–based biotech Mural Oncology announced that it will end its phase III trial of nemvaleukin alfa, an engineered fusion protein that selectively binds to the intermediate-affinity IL2 ...